Rocket Pharmaceuticals (RCKT) Earnings
|
Expand Research on RCKT
| Next EPS Date | 11/8/23 | EPS Growth Rate | -3.8% |
|---|---|---|---|
| Average EPS % Beat Rate | +3.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +4.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/8/23 | Q323 | N/A | -$0.82 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/9/23 | Q223 | N/A | -$0.79 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/10/23 | Q123 | N/A | -$0.84 | N/A | N/A | $875K | N/A | N/A | N/A | ||
| 2/27/23 | Q422 | -$0.92 | -$0.77 | -$0.15 | N/A | N/A | N/A |  | | Details | |
| 11/3/22 | Q322 | -$0.79 | -$0.78 | -$0.01 | N/A | N/A | N/A | | | Details | |
| 8/8/22 | Q222 | -$0.55 | -$0.68 | +$0.13 | N/A | N/A | N/A | | | Details | |
| 8/9/21 |  |
Q221 | -$0.55 | -$0.65 | +$0.10 | N/A | N/A | N/A | | | Details |
